AstraZeneca PLC Stock price Nasdaq

Equities

AZN

US0463531089

Pharmaceuticals

Market Closed - Nasdaq 03:59:50 2024-03-04 pm EST Pre-market 07:50:35 am
64.8 USD +0.30% Intraday chart for AstraZeneca PLC 64.9 +0.17%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 50.95B Sales 2025 * 54.55B Capitalization 198B
Net income 2024 * 8.76B Net income 2025 * 10.26B EV / Sales 2024 * 4.24 x
Net Debt 2024 * 18.4B Net Debt 2025 * 12.34B EV / Sales 2025 * 3.85 x
P/E ratio 2024 *
23 x
P/E ratio 2025 *
19.5 x
Employees 89,900
Yield 2024 *
2.43%
Yield 2025 *
2.54%
Free-Float 96.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.30%
1 week-1.72%
Current month+0.99%
1 month-1.29%
3 months-0.35%
6 months-4.91%
Current year-3.79%
More quotes
1 week
63.74
Extreme 63.74
65.78
1 month
60.47
Extreme 60.47
67.09
Current year
60.47
Extreme 60.47
69.91
1 year
60.47
Extreme 60.47
76.56
3 years
47.66
Extreme 47.66
76.56
5 years
36.15
Extreme 36.15
76.56
10 years
25.55
Extreme 25.55
76.56
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12-09-30
Director of Finance/CFO 50 21-07-31
Chief Tech/Sci/R&D Officer 56 19-12-31
Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Corporate Officer/Principal 59 13-01-31
Director/Board Member 63 17-04-26
More insiders
Date Price Change Volume
24-03-04 64.79 +0.29% 4,406,692
24-03-01 64.6 +0.69% 3,966,502
24-02-29 64.16 -1.82% 6,084,729
24-02-28 65.35 -1.48% 6,030,832
24-02-27 66.33 +0.61% 4,433,595

Delayed Quote Nasdaq, March 04, 2024 at 03:59 pm EST

More quotes
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (96.9%). Net sales break down by treatment area between oncology (34%), cardiovascular, renal and metabolic diseases (21.4%), respiratory and autoimmune diseases (13.4%), and other (31.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (3.1%). Net sales are distributed geographically as follows: the United Kingdom (7%), Europe (20.1%), Americas (44.2%) and Africa/Asia/Australia (28.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
127.6 USD
Average target price
161.7 USD
Spread / Average Target
+26.80%
Consensus
  1. Stock
  2. Equities
  3. Stock AstraZeneca PLC
  4. Stock AstraZeneca PLC - Nasdaq
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW